CymaBay Therapeutics, Inc.
CBAY · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$105 | -$106 | -$90 | -$51 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | -$3 | $0 | $1 | $0 |
| Stock-Based Comp. | $15 | $10 | $10 | $7 |
| Change in WC | $6 | -$2 | $6 | -$2 |
| Other Non-Cash | $14 | $14 | $3 | -$0 |
| Operating Cash Flow | -$73 | -$84 | -$69 | -$45 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | -$8 | -$1 | $1 | -$0 |
| Inv. Purchases | -$306 | -$175 | -$78 | -$176 |
| Inv. Sales/Matur. | $220 | $129 | $127 | $224 |
| Other Inv. Act. | $8 | $1 | -$1 | $0 |
| Investing Cash Flow | -$87 | -$46 | $49 | $48 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $346 | $0 | $70 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $346 | $25 | $118 | $0 |
| Financing Cash Flow | $346 | $25 | $118 | $0 |
| Forex Effect | -$0 | $0 | $0 | $0 |
| Net Chg. in Cash | $186 | -$106 | $98 | $3 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20 | $126 | $28 | $25 |
| End Cash | $207 | $20 | $126 | $28 |
| Free Cash Flow | -$73 | -$84 | -$70 | -$45 |